全文获取类型
收费全文 | 19042篇 |
免费 | 1263篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 220篇 |
儿科学 | 431篇 |
妇产科学 | 353篇 |
基础医学 | 2645篇 |
口腔科学 | 319篇 |
临床医学 | 1648篇 |
内科学 | 4865篇 |
皮肤病学 | 411篇 |
神经病学 | 1634篇 |
特种医学 | 646篇 |
外国民族医学 | 5篇 |
外科学 | 2673篇 |
综合类 | 238篇 |
一般理论 | 8篇 |
预防医学 | 1421篇 |
眼科学 | 416篇 |
药学 | 1166篇 |
中国医学 | 77篇 |
肿瘤学 | 1203篇 |
出版年
2023年 | 132篇 |
2022年 | 330篇 |
2021年 | 552篇 |
2020年 | 310篇 |
2019年 | 456篇 |
2018年 | 520篇 |
2017年 | 350篇 |
2016年 | 369篇 |
2015年 | 454篇 |
2014年 | 625篇 |
2013年 | 849篇 |
2012年 | 1359篇 |
2011年 | 1366篇 |
2010年 | 784篇 |
2009年 | 674篇 |
2008年 | 1130篇 |
2007年 | 1208篇 |
2006年 | 1184篇 |
2005年 | 1112篇 |
2004年 | 1016篇 |
2003年 | 966篇 |
2002年 | 956篇 |
2001年 | 144篇 |
2000年 | 129篇 |
1999年 | 172篇 |
1998年 | 201篇 |
1997年 | 165篇 |
1996年 | 167篇 |
1995年 | 124篇 |
1994年 | 115篇 |
1993年 | 101篇 |
1992年 | 114篇 |
1991年 | 105篇 |
1990年 | 101篇 |
1989年 | 78篇 |
1988年 | 86篇 |
1987年 | 89篇 |
1986年 | 70篇 |
1985年 | 92篇 |
1984年 | 104篇 |
1983年 | 96篇 |
1982年 | 112篇 |
1981年 | 125篇 |
1980年 | 107篇 |
1979年 | 66篇 |
1978年 | 79篇 |
1977年 | 88篇 |
1976年 | 64篇 |
1975年 | 50篇 |
1974年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
3.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
4.
5.
Jos M. Martín Encarnacion Montesinos Pilar Cordero Victor Gonzalez Dolores Ramon 《Pediatric dermatology》2019,36(2):265-267
Trichotillomania is a form of traction alopecia resulting from repetitive and compulsive hair pulling and plucking. Trichotillomania and patchy alopecia areata may have similar clinical and dermoscopic features in some cases. On trichoscopic examination, the presence of black dots, coiled or hook hair, shafts of varying lengths with fraying or split ends (trichoptilosis), and an absence of exclamation mark hairs and yellow dots are suggestive of trichotillomania. 相似文献
6.
7.
8.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
9.
10.
Victor Aboyans Louis Labrousse Philippe Lacroix Jér?me Guilloux Seifeddine Sekkal Alexandre Le Guyader Elisabeth Cornu Marc Laskar 《European journal of cardio-thoracic surgery》2006,30(2):300-304
BACKGROUND: Despite major improvement in surgical techniques and intensive care management, stroke remains one of the most devastating complications of coronary artery bypass grafting (CABG). We aimed to determine factors predicting the occurrence of stroke during CABG. A special interest was focused on preoperative therapies. METHODS: We prospectively enrolled 810 consecutive candidates for CABG alone in a specific database, including all pre- and perioperative data (history, clinical, therapeutic, cardiac catheterization, surgical and intensive care data). Univariate tests and then multiple logistic regression analysis were used to determine independent predictive factors. RESULTS: During the first postoperative month, stroke occurred in 11 cases and transient ischemic attack (TIA) in 4 additive cases (cumulative rate: 1.85%). After the multivariate analysis, the following factors remained significant (p<0.05) in the predictive model, with corresponding odds ratios between brackets: redo cardiac surgery (7.45), unstable cardiac status (4.74), past history of cerebrovascular disease (4.14), past history of peripheral arterial disease (3.55), whereas the presence of preoperative statins was protective (0.24, 95% IC: 0.07-0.78). The addition of perioperative data (aortic calcification, postoperative arrhythmia, on/off-pump surgery) did not change the final predictive model. CONCLUSION: To our knowledge, this is the first real-world observational report highlighting the interest of statins for the prevention of stroke in the very special situation of CABG. Even though according to randomized trials coronary patients have a benefit from these drugs, a special level of interest should be directed towards those presenting the above-mentioned risk factors. 相似文献